Avidity Biosciences Share Holder Equity 2019-2022 | RNA

Avidity Biosciences share holder equity from 2019 to 2022. Share holder equity can be defined as the sum of preferred and common equity items
Avidity Biosciences Annual Share Holder Equity
(Millions of US $)
2021 $381
2020 $306
2019 $69
2018 $0
Avidity Biosciences Quarterly Share Holder Equity
(Millions of US $)
2022-03-31 $376
2021-12-31 $381
2021-09-30 $395
2021-06-30 $264
2021-03-31 $286
2020-12-31 $306
2020-09-30 $320
2020-06-30 $330
2020-03-31 $0
2019-12-31
2019-09-30 $0
2019-06-30 $0
2018-12-31 $0
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.728B $0.009B
Avidity Biosciences Inc. is a biopharmaceutical company pioneering a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates(TM). The company's AOC platform design, engineer and develop therapeutics which combine the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide therapies. Its lead product candidate consist AOC 1001, is designed to treat myotonic dystrophy type 1,and other muscle programs are focused on the treatment of muscle atrophy, Duchenne muscular dystrophy, facioscapulohumeral muscular dystrophy and Pompe disease. Avidity Biosciences Inc. is based in SAN DIEGO.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $162.107B 9.86
Bio-Rad Laboratories (BIO.B) United States $15.121B 32.79
QIAGEN (QGEN) Netherlands $10.761B 16.99
Biohaven Pharmaceutical Holding (BHVN) United States $10.111B 0.00
Ginkgo Bioworks Holdings (DNA) United States $5.648B 0.00
Emergent Biosolutions (EBS) United States $1.770B 7.57
Arcus Biosciences (RCUS) United States $1.376B 34.89
Myovant Sciences (MYOV) United Kingdom $1.033B 0.00
Zymeworks (ZYME) Canada $0.397B 0.00
Gelesis Holdings (GLS) United States $0.345B 0.00
Ambrx Biopharma (AMAM) United States $0.157B 0.00
Enzo Biochem (ENZ) United States $0.110B 22.60
SQZ Biotechnologies (SQZ) United States $0.100B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.000B 0.00